Sign up to save your podcasts
Or
Share How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm
Welcome to another episode of the Oncology Brothers! In this episode, Drs. Rahul and Rohit Gosain are joined by their brother, Dr. Timothy Brown from UT Southwestern, to discuss the latest treatment paradigms for upper gastrointestinal (GI) malignancies, specifically focusing on esophageal and gastroesophageal junction adenocarcinoma, as well as gastric cancer.
Episode Highlights:
• Early Disease Management: perioperative FLOT versus concurrent chemoradiation.
• Adjuvant Nivolumab: Insights from the Checkmate 577 trial and its implications for patients with residual disease post-chemoradiation.
• Biomarker Testing: The importance of testing for MSI, HER2, Claudin 18.2, and PD-L1 to guide treatment decisions in metastatic settings.
• Patient-Centered Care: Emphasizing the significance of shared decision-making and multidisciplinary approaches in managing complex cases.
Join us as we unpack the nuances of upper GI malignancies and share key takeaways from recent studies and clinical practices.
YouTube: https://youtu.be/UNyi71u2wIw
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more updates on treatment algorithms and oncology insights!
View all episodes
By Oncology Brothers
4.8
4040 ratings
Welcome to another episode of the Oncology Brothers! In this episode, Drs. Rahul and Rohit Gosain are joined by their brother, Dr. Timothy Brown from UT Southwestern, to discuss the latest treatment paradigms for upper gastrointestinal (GI) malignancies, specifically focusing on esophageal and gastroesophageal junction adenocarcinoma, as well as gastric cancer.
Episode Highlights:
• Early Disease Management: perioperative FLOT versus concurrent chemoradiation.
• Adjuvant Nivolumab: Insights from the Checkmate 577 trial and its implications for patients with residual disease post-chemoradiation.
• Biomarker Testing: The importance of testing for MSI, HER2, Claudin 18.2, and PD-L1 to guide treatment decisions in metastatic settings.
• Patient-Centered Care: Emphasizing the significance of shared decision-making and multidisciplinary approaches in managing complex cases.
Join us as we unpack the nuances of upper GI malignancies and share key takeaways from recent studies and clinical practices.
YouTube: https://youtu.be/UNyi71u2wIw
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more updates on treatment algorithms and oncology insights!
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
319 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Research To Practice | Oncology Videos
116 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
289 Listeners
White Coat Investor Podcast
2,431 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
The ONS Podcast
199 Listeners
OncoPharm
184 Listeners
ASCO Guidelines
44 Listeners
OncLive® On Air
21 Listeners
Becker’s Healthcare Podcast
189 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Two Onc Docs
185 Listeners